Last edition
News about "Abbreviated New Drug Applications "
Senores Pharmaceuticals to Acquire Apnar Pharma and Five ANDAs
Senores Pharmaceuticals has entered into an agreement to acquire 100 percent equity in Apnar Pharma, along with a portfolio of five Abbreviated New Drug Applications (ANDAs), as part of its strategy to expand its footprint in regulated pharmaceutical markets.
Abbreviated New Drug Applications | 18/12/2025 | By Darshana
Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility
The Dahej facility was placed under OAI by the USFDA based on the March 2019 Inspection outcome.
Abbreviated New Drug Applications | 25/08/2023 | By Manvi | 1364
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy